LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) and Ayr Wellness (OTCMKTS:AYRWF – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, earnings, profitability and dividends.
Risk and Volatility
LeMaitre Vascular has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500. Comparatively, Ayr Wellness has a beta of 1.68, suggesting that its stock price is 68% more volatile than the S&P 500.
Institutional & Insider Ownership
84.6% of LeMaitre Vascular shares are held by institutional investors. Comparatively, 0.9% of Ayr Wellness shares are held by institutional investors. 9.5% of LeMaitre Vascular shares are held by insiders. Comparatively, 8.1% of Ayr Wellness shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| LeMaitre Vascular | 0 | 4 | 3 | 1 | 2.63 |
| Ayr Wellness | 0 | 1 | 0 | 0 | 2.00 |
LeMaitre Vascular currently has a consensus target price of $100.20, suggesting a potential upside of 20.78%. Given LeMaitre Vascular’s stronger consensus rating and higher probable upside, equities analysts clearly believe LeMaitre Vascular is more favorable than Ayr Wellness.
Valuation and Earnings
This table compares LeMaitre Vascular and Ayr Wellness”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| LeMaitre Vascular | $240.87 million | 7.81 | $44.04 million | $2.32 | 35.76 |
| Ayr Wellness | $463.63 million | 0.00 | -$359.31 million | ($2.67) | 0.00 |
LeMaitre Vascular has higher earnings, but lower revenue than Ayr Wellness. Ayr Wellness is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares LeMaitre Vascular and Ayr Wellness’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| LeMaitre Vascular | 20.08% | 13.67% | 9.14% |
| Ayr Wellness | -68.53% | -42.25% | -13.91% |
Summary
LeMaitre Vascular beats Ayr Wellness on 13 of the 15 factors compared between the two stocks.
About LeMaitre Vascular
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient’s body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
About Ayr Wellness
Ayr Wellness Inc. operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names. The company was formerly known as Ayr Strategies Inc. and changed its name to Ayr Wellness Inc. in February 2021. Ayr Wellness Inc. was incorporated in 2017 and is headquartered in Miami, Florida.
Receive News & Ratings for LeMaitre Vascular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LeMaitre Vascular and related companies with MarketBeat.com's FREE daily email newsletter.
